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A biomarker or biological marker is defined as an
indicator of a biological state or existence in the past of a
particular type of organism. Biomarkers are objectively
measured and evaluated as indicators of normal biological
processes, pathogenic processes, or pharmacologic
responses to a therapeutic intervention. Over the last two
decades such biomarkers have been developed in many
fields of medicine : such as in cell biology where a mole-
cule is used as a biomarker to detect and isolate a particu-
lar cell type, in genetics where a DNA sequence is
associated with the cause of or susceptibility to a disease,
in pharmacology where biomarkers provide a molecular
impression of a biological system (cell, animal or human)
such as a blood PSA protein as an indicator of prostate
cancer or blood cholesterol as a risk indicator of vascular
disease etc. A recent analysis on biomarker innovation
shows a huge gap between the discovery of biomarkers on
one hand and the development into diagnostic application
on the other. Very few biomarkers progress after initial
discovery and publication to clinical validation, confirma-
tion and at the end diagnostic application due to many
complex factors such as limited confirmation of initial
findings by other laboratories, rare quantitative clinical
validation of biomarkers by single test and multi labora-
tory research and very limited progress of validated
biomarker to applicable molecular diagnostic tests. In
pharmacology a biomarker definition working group was
initiated in 2001. Ten years later several initiatives to
further develop uniformity in terminology, data acquisi-
tion, data processing and post processing etc have been
integrated in the QIBA group which works its way
through this enormous field of developing Imaging
biomarkers [1]. An Imaging Biomaker can be defined as a
single quantitative unit acquired by an imaging modality
and expressing morphology or function of a cell, tissue or
organ, which objectively measured and evaluated as a
prognostic indicator of normal, physiological and patho-
genic processes. This definition should be distinguished
from an image phenotype which is a set of multiple
acquired quantitative measurements obtained from digital
imaging data as parameters for personalized characteriza-
tion of the subject examined. An imaging biomarker
should be accurate, reproducible, objective, quantitative,
standardizable and robust. For successful implementation
an imaging biomarker has to be fast applicable, widely
available and cheap. Furthermore an imaging biomarker
should deliver a single parameter on which clinical
decisions can be taken. In this manner imaging biomarkers
can be directly compared to other non imaging biomar-
kers in any diagnostic management algorithm. For imaging
biomarkers there is the same long development road as for
non-imaging biomarkers with the same huge innovation
gap. Many candidates but very few which reach the
maturity to clinical application. Each imaging modality has
its specific strengths and weaknesses from which in a
further analysis the candidates with the best chances can
be deducted and selected for further development to clini-
cal implementation. Only in systematic development path-
ways this goal can be reached and imaging can come to
another era beyond the image.
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